切换至 "中华医学电子期刊资源库"
高级检索
中华普通外科学文献(电子版)

中华普通外科学文献(电子版) ›› 2014, Vol. 08 ›› Issue (04) : 321 -331. doi: 10.3877/cma.j.issn.1674-0793.2014.04.018

所属专题： 文献；

循证医学

袖状胃切除及胃旁路手术对合并肥胖2型糖尿病近、远期疗效的Meta分析
汤聪1, 梁文丰1,†(), 岑宏1, 陈强1   
  1. 1. 519000　珠海，中山大学附属第五医院普外4科微创中心
  • 收稿日期:2014-04-24 出版日期:2014-08-01
  • 通信作者: 梁文丰

Short- and long-term remission of obese type 2 diabetes mellitus after gastric bypass surgery or sleeve gastrectomy: a Meta analysis

Cong Tang1, Wenfeng Liang1,†(), Hong Cen1, Qiang Chen1   

  1. 1. Department of General Surgery, the Fifth Affiliated Hospital of Sun Yat-sen University, Guangzhou 519000, China
  • Received:2014-04-24 Published:2014-08-01
  • Corresponding author: Wenfeng Liang
  • About author:
    Corresponding author: Liang Wenfeng, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

汤聪, 梁文丰, 岑宏, 陈强. 袖状胃切除及胃旁路手术对合并肥胖2型糖尿病近、远期疗效的Meta分析[J/OL]. 中华普通外科学文献(电子版), 2014, 08(04): 321-331.

Cong Tang, Wenfeng Liang, Hong Cen, Qiang Chen. Short- and long-term remission of obese type 2 diabetes mellitus after gastric bypass surgery or sleeve gastrectomy: a Meta analysis[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2014, 08(04): 321-331.

目的

探讨袖状胃切除术（SG）及胃转流术（GBP）对2型糖尿病（T2DM）的近、长期疗效的循证支持。

方法

检索Cochrane图书馆、Medline及EMbase数据库关于SG及GBP手术治疗合并肥胖的T2DM患者疗效的文献，设立纳入与排除标准筛选文献，进行质量评价、提取数据和数据统计分析。

结果

纳入Meta分析标准的文章有34篇，其中8篇为RCT，26项研究涉及GBP，27项研究涉及SG。术前GBP及SG手术患者的基础BMI（kg/m2）分别为44.8±5.2、46.68±7.3；术前指标糖化血红蛋白（%）分别为7.86±0.73、7.91±0.98；空腹血糖水平（mg/dl，1mg/dl=0.055 5 mmol/L）分别为158.0±18.1、167.7±41.6。随访1年GBP和SG术后T2DM缓解率分别为77%、74%，3年缓解率则为74%、85%，5年及以上缓解率分别为77%、74%。8篇RCT文献中行GBP与SG手术治疗T2DM效果的Meta分析，RR=1.26，95% CI=1.10~1.44，GBP术后T2DM缓解率较SG高。

结论

GBP及SG手术均是治疗肥胖合并T2DM的有效措施，其近、远期疗效随随访时间无明显下降。GBP治疗T2DM的疗效优于SG手术。

关键词: 袖状胃切除术, 胃转流手术, 2型糖尿病, 远期疗效, 缓解率
Objective

To analyze the evidence-based study of short-term and long-term remission of type 2 diabetes mellitus(T2DM) after sleeve gastrectomy(SG) or gastric bypass surgery(GBP).

Methods

Related articles were systematically retrieved by searching Medline, Embase database, and Cochrane library. Inclusion and exclusion criteria to select literatures were set up. The data were qualitatively evaluated and analyzed by STATA or SPSS software.

Results

Thirty-four articles were involved including 8 randomized controlled trials (RCTs). Among them, 26 studies were on GBP surgeries and 27 on SG. The preoperative BMI of GBP and SG group were (44.8±5.2) kg/m2 and (46.68±7.3) kg/m2, preoperative glycosylated hemoglobin index were (7.86±0.73)% and (7.91±0.98)%, preoperative fasting plasma glucose were (158.0±18.1) mg/dl and (167.7±41.6)mg/dl, retrospectively. After 1 year of follow-up, the remission rate of T2DM was 77% and 74% in GBP and SG groups, while the remission rate was 74% and 85% in follow-up of 3 years. In follow-up of 5 or more years, the remission rate of SG surgery was 77%, while that of GBP group was 74% according to the Meta analysis. Comparing the remission rate of T2DM in GBP and SG group from the 8 RCTs, the RR was 1.26, 95% CI=1.10-1.44. The difference between the two groups was statistically significant (P<0.01).

Conclusion

Both SG and GBP surgeries are effective treatments for obese T2DM. The remission rate of GBP surgery is higher than SG.

Key words: Sleeve gastrectomy(SG), Gastric bypass surgery(GBP), Type 2 diabetes mellitus, Long-term efficacy, Remission
表1 纳入文章质量评分标准
分类 内容 评分
选择偏倚 连续或者有代表性的研究（包括随机非随机临床试验或） 1
失访偏倚 随访率>80% 1
实施偏倚 组间实施及干预相同 1
检出偏倚 随机或者前瞻性临床研究 1
双盲或者独立临床试验 1
验证/客观结果 1
图1 研究纳入筛选流程图
表2 纳入研究的合并肥胖的糖尿病患者基本特征
项目 胃旁路手术（GBP） 袖状胃切除术（SG）
病例数 1 325 1 165
糖尿病患病时间（年） 6.24±1.59 6.56±2.7
年龄（岁） 45.1±4.9 44.1±1.9
基础体重指数（BMI，kg/m2） 44.8±5.2 46.68±7.3
糖化血红蛋白（HbA1c，%） 7.86±0.73 7.91±0.98
空腹血糖（FPG，mg/dl） 158.0±18.1 167.7±41.6
图2 袖状胃切除术（SG）后随访1年，T2DM缓解率的单个率Meta分析，n：研究手术患者例数，合并随访1年的T2DM缓解率为74%
图3 胃转流（GBP）术后随访1年，糖尿病缓解率的单个率Meta分析图，合并缓解率为77%，n为手术例数
图4 袖状胃切除术（SG）术后随访3年，T2DM缓解率进行单个率的Meta分析图，合并缓解率为85%
图5 胃转流术（GBP）术后3年随访，T2DM缓解率的单个率Meta分析，合并完全缓解率为74%
图6 袖状胃切除术（SG）术后随访5年，T2DM缓解率的单个率Meta分析，合并的缓解率为77%
图7 胃转流术（GBP）术后随访5年至11.4年，T2DM缓解率Meta分析，合并的缓解率为74%。n为手术例数
表3 SG术后随访5年2型糖尿病完全缓解率
文献，出版年 患病时间（年） 血糖水平（mg/dl） HbA1c（%） 例数 年龄（岁） BMI（kg/m2） T2DM术后5年缓解率（%）
Abbatini等，2013[15] - 143.2 7.30 13 49.3 52.1 76.9
Brethauer等，2013[50] 10.5 137 7.8 23 57.7 50.7 74
Zachariah等，2013[29] - - - 3 34.6 37.42 66.66
Rawlins等，2013[51] - - - 19 44 65 100
Catheline等，2013[52] - - - 13 41.8 49.91 61.5
Sieber等，2014[53] - - - 20 43 46 85
表4 T2DM患者GBP术后5年及5年以上缓解率
研究，出版年 例数 缓解率（%） 随访时间（年） BMI（kg/m2）
Aftab等，2014[54] 49 67.35 5 46± 5
Davies等，2014[55] 70 60.00 5 52±10
DiGiorgi等，2010[56] 42 64.00 5 51.4±8.7
Adams等，2012[57] 87 62.00 6 47.3±7.7
Cohen等，2012[58] 66 88.00 6 30-35
Obeid等，2012l[59] 77 82.00 6.3 46
Pajecki等，2007[60] 17 76.50 7.2 56.7
Davies等，2014[55] 48 44.00 10 52±10
Edholm等，2013[61] 18 72.00 11.4 44.5
图8 胃转流术（GBP）与袖状胃切除术（SG）治疗T2DM之间缓解率的Meta分析
表5 8项随机对照试验的详细数据
研究者，出版年 例数 BMI（kg/m2） HBA1c（%） 缓解率% 随访时间（月） 质量评分
GBP SG GBP SG GBP SG GBP SG
Schauer等，2012[30] 38 51 37.0 36.2 9.3 9.5 78 51 12 6
Ramón等，2012[2] 2 2 44.2 43.5 - - 100 100 12 4
Paluszkiewicz等，2012[24] al.2012[64] 14 10 48.6 46.1 - - 64.3 40 12 5
Nocca等，2011[11] 35 33 48 50.6 8.2 7.8 68.5 72 12 6
Lee等，2011[34] 30 30 30.3 30.3 10.0 10.0 93 47 12 6
Kehagias等，2011[62] 5 5 45.8 44.9 - - 80 80 36 5
Helmi?等，2012[63]，2014[64] al.2012,2014[66,67] 50 51 44.6 44.6 - - 51.0 41.0 6 6
Boza等，2012[12] 43 32 38 37.9 - - 86.6 90.9 36 5
图9 SG与GBP术后，随访时间分别在6,12,36,60个月及以上时间点时，T2DM完全缓解率的比较图。*表示经χ2检验两者差别有统计学意义（P<0.01）
图10 纳入关于LSG术后随访研究中，4项研究记录不同时间点随访缓解率变化情况。（LSG腹腔镜下袖状胃切除术）
[1]
Yang W,Lu J,Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12): 1090-1101.
[2]
Ramón JM,Salvans S,Crous X, et al. Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial[J]. J Gastrointest Surg, 2012, 16(6): 1116-1122.
[3]
World Health Organization. Diabetes Fact Sheet No. 312[DB/OL]. (2011-08-01)August 2011.

URL    
[4]
Cummings DE,Overduin J,Shannon MH, et al. Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery[J]. Surg Obes Relat Dis, 2005,1(3): 358-368.
[5]
Bayham BE,Greenway FL,Bellanger DE, et al. Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy[J]. Diabetes Technol Ther, 2012,14(1): 30-34.
[6]
Ochner CN,Gibson C,Shanik M, et al. Changes in neurohormonal gut peptides following bariatric surgery[J]. Int J Obes (Lond), 2011 35(2): 153-166.
[7]
Buchwald H,Estok R,Fahrbach K, et al. Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis[J]. Am J Med, 2009, 122(3): 248-256.
[8]
Franco JV,Ruiz PA,Palermo M, et al. A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding[J]. Obes Surg, 2011, 21(9): 1458-1468.
[9]
汤朝晖, Hussain M,Prachand VN, 等. 腹腔镜袖状胃切除治疗病态性肥胖及2型糖尿病的意义及国际专家共识[J]. 中国实用外科杂志, 2013, 33 (1): 13-16.
[10]
Mingrone G,Panunzi S,De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes[J]. N Engl J Med, 2012, 366(17): 1577-1585.
[11]
Nocca D,Guillaume F,Noel P, et al. Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year[J]. Obes Surg, 2011, 21(6): 738-743.
[12]
Boza C,Gamboa C,Salinas J, et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: a case-control study and 3 years of follow-up[J]. Surg Obes Relat Dis, 2012, 8(3): 243-249.
[13]
Robert M,Ferrand-Gaillard C,Disse E, et al. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: Impact of surgical techniques[J]. Obes Surg, 2013, 23(6): 770-775.
[14]
Taylor RS. Spinal cord stimulation in complex regional pain syndrome and refractory neuropathic back and leg pain/failed back surgery syndrome: results of a systematic review and meta-analysis[J]. J Pain Symptom Manage, 2006, 31(4 Suppl): S13-19.
[15]
Abbatini F,Capoccia D,Casella G, et al. Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy[J]. Surg Obes Relat Dis, 2013, 9(4): 498-502.
[16]
Cutolo PP,Nosso G,Vitolo G, et al. Clinical efficacy of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass in obese type 2 diabetic patients: A retrospective comparison[J]. Obes Surg, 2012, 22(10): 1535-1539.
[17]
Desiderio J,Trastulli S,Scalercio V, et al. Laparoscopic Sleeve Gastrectomy and Medical Management for the Treatment of Type 2 Diabetes Mellitus in Non-Morbidly Obese Patients: A Single-Center Experience[J]. Diabetes Technol Ther, 2013, 15(4): 281-288.
[18]
Lakdawala M, Bhasker A, Asian Consensus Meeting on Metabolic Surgery (ACMOMS). Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of Bariatric and Gastrointestinal Metabolic Surgery for Treatment of Obesity and Type II Diabetes Mellitus in the Asian Population[J]. Obes Surg, 2010, 20(7): 929-936.
[19]
Lee WJ,Wang W,Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2[J]. J Gastrointest Surg, 2008, 12(5): 945-952.
[20]
Chowbey PK,Dhawan K,Khullar R, et al. Laparoscopic sleeve gastrectomy: an Indian experience-surgical technique and early results[J]. Obes Surg, 2010, 20(10): 1340-1347.
[21]
Kasalicky M,Michalsky D,Housova J, et al. Laparoscopic sleeve gastrectomy without an over-sewing of the staple line[J]. Obes Surg, 2008,18(10): 1257-1262.
[22]
Nocca D. Laparoscopic adjustable gastric banding and laparoscopic sleeve gastrectomy: which has a place in the treatment of diabetes in morbidly obese patients?[J]. Diabetes Metab, 2009, 35(6 Pt 2): 524-527.
[23]
Nienhuijs SW,de Zoete JP,Berende CA, et al. Evaluation of laparoscopic sleeve gastrectomy on weight loss and co-morbidity[J]. Int J Surg, 2010, 8(4): 302-304.
[24]
Paluszkiewicz R,Kalinowski P,Wroblewski T, et al. Prospective randomized clinical trial of laparoscopic sleeve gastrectomy versus open Roux-en-Y gastric bypass for the management of patients with morbid obesity[J]. Wideochir Inne Tech Malo Inwazyjne, 2012, 7(4): 225-232.
[25]
Sammour T,Hill AG,Singh P, et al. Laparoscopic sleeve gastrectomy as a single-stage bariatric procedure[J]. Obes Surg, 2010, 20(3): 271-275.
[26]
Shah PS,Todkar JS,Shah SS. Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus[J]. Surg Obes Relat Dis, 2010, 6(2): 138-141.
[27]
Tagaya N,Kasama K,Kikkawa R, et al. Experience with Laparoscopic sleeve gastrectomy for morbid versus super morbid obesity[J]. Obes Surg, 2009, 19(10): 1371-1376.
[28]
Vidal J,Ibarzabal A,Romero F, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects[J]. Obes Surg, 2008, 18(9): 1077-1082.
[29]
Zachariah SK,Chang P-C,Ooi AS, et al. Laparoscopic sleeve gastrectomy for morbid obesity: 5 years experience from an Asian center of excellence[J]. Obes Surg, 2013, 23(7): 939-946.
[30]
Schauer PR,Kashyap SR,Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes[J]. N Engl J Med, 2012, 366(17):1567-1576.
[31]
Araia M,Wood M,Kroll J, et al. Resolution of Diabetes After Bariatric Surgery Among Predominantly African-American Patients[J]. Obes Surg, 2014, 24(6): 835-840.
[32]
Weiner RA,Weiner S,Pomhoff I, et al. Laparoscopic sleeve gastrectomy-Influence of sleeve size and resected gastric volume[J]. Obes Surg, 2007, 17(10): 1297-1305.
[33]
Lee WJ,Ser KH,Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: Efficacy and change of insulin secretion[J]. Surgery, 2010, 147(5): 664-669.
[34]
Lee WJ,Chong K,Ser KH,et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: A randomized controlled trial[J]. Arch Surg, 2011, 146(2):143-148.
[35]
Boza C,Muñoz R,Salinas J, et al. Safety and efficacy of roux-en-y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients[J]. Obes Surg, 2011, 21(9):1330-1336.
[36]
Dalmas E,Rouault C,Abdennour M, et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction1-3[J]. Am J Clin Nutr2011 , 94(2): 450-458.
[37]
Demssie YN,Jawaheer J,Farook S, et al. Metabolic outcomes 1 year after gastric bypass surgery in obese people with type 2 diabetes[J]. Med Princ Pract, 2012, 21(2): 125-128.
[38]
Dorman RB,Serrot FJ,Miller CJ, et al. Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient[J]. Ann Surg, 2012, 255(2): 287-293.
[39]
Huang CK,Shabbir A,Lo CH, et al. Laparoscopic roux-en-y gastric bypass for the treatment of type ii diabetes mellitus in chinese patients with body mass index of 25-35[J]. Obes Surg, 2011, 21(9): 1344-1349.
[40]
Kim S,Richards WO. Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after roux-en-Y gastric bypass[J]. Ann Surg, 2010, 251(6): 1049-1055.
[41]
Lakdawala MA,Bhasker A,Mulchandani D, et al. Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic roux-en-y gastric bypass in the Indian population: A retrospective 1 year study[J]. Obes Surg, 2010, 20(1): 1-6.
[42]
Mumme DE,Mathiason MA,Kallies KJ, et al. Effect of laparoscopic Roux-en-Y gastric bypass surgery on hemoglobin A1c levels in diabetic patients: a matched-cohort analysis[J]. Surg Obes Relat Dis, 2009, 5(1): 4-10.
[43]
Smith BR,Hinojosa MW,Reavis KM, et al. Remission of diabetes after laparoscopic gastric bypass[J]. Am Surg, 2008, 74(10): 948-952.
[44]
Vidal P,Ramón JM,Goday A, et al. Laparoscopic gastric bypass versus laparoscopic sleeve gastrectomy as a definitive surgical procedure for morbid obesity. Mid-term results[J]. Obes Surg, 2013, 23(3): 292-299.
[45]
Abbatini F,Rizzello M,Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes[J]. Surg Endosc, 2009, 24(5): 1005-1010.
[46]
Jiménez A,Casamitjana R,Flores L, et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.[J]. Ann Surg, 2012, 256(6): 1023-1029.
[47]
Todkar JS,Shah SS,Shah PS, et al. Long-term effects of laparoscopic sleeve gastrectomy in morbidly obese subjects with type 2 diabetes mellitus[J]. Surg Obes Relat Dis, 2010, 6(2): 142-145.
[48]
Basso N,Casella G,Rizzello M, et al. Laparoscopic sleeve gastrectomy as first stage or definitive intent in 300 consecutive cases[J]. Surg Endosc, 2011, 25(2): 444-449.
[49]
Pournaras DJ,Osborne A,Hawkins SC, et al. Remission of type 2 diabetes after gastric bypass and banding: Mechanisms and 2 year outcomes[J]. Ann Surg, 2010, 252(6): 966-971.
[50]
Brethauer SA,Aminian A,Romero-Talamás H, et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus[J] . Ann Surg, 2013, 258(4): 628-636.
[51]
Rawlins L,Rawlins MP,Brown CC, et al. Sleeve gastrectomy: 5-year outcomes of a single institution[J]. Surg Obes Relat Dis, 2013, 9(1): 21-25.
[52]
Catheline JM,Fysekidis M,Bachner I, et al. Five-year results of sleeve gastrectomy[J]. J Visc Surg, 2013, 150(5): 307-312.
[53]
Sieber P,Gass M,Kern B, et al. Five-year results of laparoscopic sleeve gastrectomy[J]. Surg Obes Relat Dis, 2014,10(2): 243-249.
[54]
Aftab H,Risstad H,Søvik TT, et al. Five-year outcome after gastric bypass for morbid obesity in a Norwegian cohort[J]. Surg Obes Relat Dis, 2014,10(1):71-78.
[55]
Davies SW,Efird JT,Guidry CA, et al. Long-term diabetic response to gastric bypass[J]. J Surg Res, 2014, pii: S0022-4804(14)00087-0.
[56]
DiGiorgi M,Rosen DJ,Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up[J]. Surg Obes Relat Dis, 2010, 6(3): 249-253.
[57]
Adams TD,Davidson LE,Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years[J]. JAMA, 2012, 308(11): 1122.
[58]
Cohen RV,Pinheiro JC,Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity[J]. Diabetes Care, 2012, 35(7): 1420-1428.
[59]
Obeid A,Long J,Kakade M, et al. Laparoscopic Roux-en-Y gastric bypass: long term clinical outcomes[J]. Surg Endosc, 2012,26(12): 3515-3520.
[60]
Pajecki D,Dalcanalle L,Souza de Oliveira CP, et al. Follow-up of Roux-en-Y gastric bypass patients at 5 or more years postoperatively[J]. Obes Surg, 2007,17(5): 601-607.
[61]
Edholm D,Svensson F,Näslund I, et al. Long-term results 11 years after primary gastric bypass in 384 patients[J]. Surg Obes Relat Dis, 2013,9(5): 708-713.
[62]
Kehagias I,Karamanakos SN,Argentou M, et al. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI<50 kg/m2[J]. Obes Surg, 2011, 21(11): 1650-1656.
[63]
Helmiö M,Victorzon M,Ovaska J, et al. SLEEVEPASS: A randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: Preliminary results[J]. Surg Endosc, 2012, 26(9): 2521-2526.
[64]
Helmiö M,Victorzon M,Ovaska J, et al. Comparison of short-term outcome of laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: A prospective randomized controlled multicenter SLEEVEPASS study with 6-month follow-up[J]. Scand J Surg, 2014,12: 12.
[65]
Dixon JB,Zimmet P,Alberti KG, et al. Bariatric surgery: an IDF statement for obese Type 2 diabetes[J]. Diabet Med, 2011, 28(6): 628-642.
[66]
Rubino F,Kaplan LM,Schauer PR, et al. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus[J]. Ann Surg, 2010, 251(3): 399-405.
[67]
Yip S,Plank LD,Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes[J]. Obes Surg, 2013, 23(12): 1994-2003.
[68]
Li P,Fu P,Chen J, et al. Laparoscopic Roux-en-Y gastric bypass vs. laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus: a meta-analysis of sixteen recent studies[J]. Hepatogastroenterology, 2012,60(121):132-137.
[69]
De Sa VC,Ferraz AA,Campos JM, et al. Gastric bypass in the treatment of type 2 diabetes in patients with a BMI of 30 to 35 kg/m2[J]. Obes Surg, 2011, 21(3): 283-287.
[70]
DePaula AL,Macedo AL,Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35[J]. Surg Endosc, 2008, 22(3): 706-716.
[71]
Kadera BE,Lum K,Grant J, et al. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss[J]. Surg Obes Relat Dis, 2009, 5(3): 305-309.
[72]
Cummings DE,Overduin J,Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution[J]. J Clin Endocrinol Metab, 2004, 89(6): 2608-2615.
[73]
Baggio LL,Drucker DJ. Biology of incretins: GLP-1 and GIP[J]. Gastroenterology, 2007,132(6): 2131-2157.
[74]
Umeda LM,Silva EA,Carneiro G, et al. Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients[J]. Obes Surg, 2011, 21(7): 896-901.
[75]
Peterli R,Wolnerhanssen B,Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial[J]. Ann Surg, 2009,250(2): 234-241.
[76]
Monteforte MJ,Turkelson CM. Morbid obesity II and selected papers in bariatric surgery[J]. Gastroenterol Clin North Am, 1987, 16(3): 389-544.
[77]
Kim MK,Lee HC,Kwon HS, et al. Visceral obesity is a negative predictor of remission of diabetes 1 year after bariatric surgery[J]. Obesity (Silver Spring), 2011,19(9):1835-1839.
[78]
Li JF,Lai DD,Lin ZH, et al. Comparison of the long-term results of Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: a systematic review and meta-analysis of randomized and nonrandomized trials[J]. Surg Laparosc Endosc Percutan Tech, 2014, 24(1): 1-11.
[79]
Himpens J,Dapri G,Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years[J]. Obes Surg, 2006, 16(11): 1450-1456.
[80]
Moy J,Pomp A,Dakin G, et al. Laparoscopic sleeve gastrectomy for morbid obesity[J]. Am J Surg, 2008, 196(5): e56-59.
[81]
Hüttl TP,Obeidat FW,Parhofer KG, et al. Operative techniques and outcomes in metabolic surgery: sleeve gastrectomy[J]. Zentralbl Chir, 2009, 134(1): 24-31.
[1] 曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(07): 709-717.
[2] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[3] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[4] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[5] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[6] 刘见, 杨晓波, 何均健, 等. 应用电钩三孔法腹腔镜袖状胃切除术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(06): 363-364.
[7] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
[8] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
[9] 李兆, 李兆鹏, 宋逸, 郭栋, 陈栋, 李宇. 腹腔镜袖状胃切除术后残胃容积的测量方案及评价[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 242-247.
[10] 王超珺, 董志勇, 赵宛鄂, 胡嵩浩, 刘昭晖. 肌少症对肥胖患者袖状胃切除术后效果的影响研究[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 283-287.
[11] 吴晓明, 翟仰魁, 王娟, 张硕, 许杰, 潘从清. 男性2 型糖尿病患者空腹C 肽和定量胰岛素敏感性检测指数与血浆致动脉粥样硬化指数的相关性[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 288-294.
[12] 孙海涛, 郝少龙, 孙武青, 韩威, 白日星. 中间入路法单孔腹腔镜袖状胃切除术：3 例报告（附视频）[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 300-304.
[13] 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会胃食管反流疾病诊疗外科专家工作组, 日本肥胖治疗学会, 韩国减重与代谢外科学会. 袖状胃切除术患者胃食管反流病诊治专家共识（2024版）[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 145-162.
[14] 郭明杰, 周春起, 余佳慧, 李世红, 朱红梅, 刘雁军, 杨华武. 肥胖与胃食管反流病的关系及减重术后反流治疗研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 184-192.
[15] 张梅, 陈卉, 李转霞, 王瑞, 李林娟. Metrnl和NLRP3炎症小体：糖尿病肾病的潜在诊断标志物[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 193-199.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号

AI
小
编
AI小编
你好！我是《中华医学电子期刊资源库》AI小编，有什么可以帮您的吗？